Most people who know anything about infectious disease don t think total eradication is possible. - Harvard Chan … https://t.co/pXN6LH6mqB
“Think about that: Asian Americans are more concerned about other Americans’ hate than they are of a pandemic that’… https://t.co/jIb0V4LQ2r
RT @CCDD HSPH: Herd immunity is often described as a national target. But that is a hazy concept in a country so large. “If coverage is 95…
May is #MentalHealthMonth. Watch the latest in the Mental Health Forum Series, hosted by @KarestanKoenen, with epis… https://t.co/pwLXcFEmpa
RT @TheWorld: What can policymakers and the public do to combat hate crimes against Asian Americans? That s the focus of our forum with @H…
Harvard Chan–affiliated teams named finalists in President’s Innovation Challenge
Two teams with ties to Harvard T.H. Chan School of Public Health are among 25 finalists in the 2021 President’s Innovation Challenge presented by the Harvard Innovation Labs.
One of the Harvard Chan–affiliated finalists is Concerto Biosciences, a venture that discovers and develops specific combinations of microbes that, working together, accomplish important functions in human health, agriculture, and industry. The venture was co-founded by Adil Bahalim, DrPH ’20, Bernardo Cervantes, Cheri Ackerman, and Jared Kehe. Concerto Biosciences won a runner-up prize ($25,000) in the Health and Life Science track in last year’s challenge.